Fellows are invited to apply for a position on the Trainee Council. Trainees who exhibit leadership qualities and a high potential for a successful career in hematology or a hematology-related discipline are desired candidates.
Second-Year Council Members
Council Chair - Alexander Boucher, MD
Dr. Alexander Boucher graduated from the University of Tennessee College of Medicine and completed his combined internal medicine and pediatrics residency at the University of Minnesota. He is currently a third-year pediatric hematology/oncology fellow at Cincinnati Children's Hospital Medical Center. Dr. Boucher’s clinical and lab-based research interests are focused on platelets and the links between coagulation and inflammation.
Puja Arora, MD
Dr. Puja Arora graduated from Wright State University Boonshoft School of Medicine and completed her internal medicine residency at Washington Hospital Center in Washington, DC. She is currently a third-year hematology/oncology fellow at the University of Virginia. Dr. Arora is interested in pursuing a career in hematologic malignancies, and her research interests are in overcoming drug resistance in non-Hodgkin lymphoma.
Jaime Gastwirt, MD
Dr. Jaime Gastwirt completed her undergraduate education at Vanderbilt University. After many years of research within the pharmaceutical industry, Dr. Gastwirt began her medical and military career at the Uniformed Services University F. Edward Hébert School of Medicine. She is currently an active duty U.S. Naval officer completing her fellowship in hematology-oncology at the Walter Reed National Military Medical Center. Dr. Gastwirt’s research interests are in the lymphoid malignancies.
Surbhi Sidana, MBBS
Dr. Surbhi Sidana is an advanced hematology fellow at Mayo Clinic in Rochester, Minnesota, where she also completed her categorical hematology/oncology fellowship in June 2018. She is passionate about advocacy for issues relevant to trainees and early career professionals. Dr. Sidana’s clinical and translational research is focused on novel prognostic factors and treatment of plasma cell disorders, as well as integration of patient-reported outcomes as key elements of clinical trials and daily practice.
Arun K. Singavi, MD
Dr. Arun Singavi completed a dual bachelor’s in Business Management and Biology at the University of Illinois-Chicago, medical school at St. George's University, and internal medicine residency at the Medical College of Wisconsin. He served as a chief resident prior to fellowship. Dr. Singavi is a third-year hematology and oncology fellow at the Medical College of Wisconsin. His research and career interests include improving patient care and decreasing physician burnout using technology and health informatics.
Andrew G. Volk, PhD
Dr. Andrew Volk received his PhD in molecular biology of stem cell development at Loyola University in Chicago. He is a postdoctoral fellow with John Crispino at Northwestern University and is currently supported by an ASH Scholar Award for basic/translational research. Dr. Volk studies how the histone chaperone CHAF1B contributes to hematopoietic stem cell function and leukemogenesis.back to top
First-Year Council Members
Bryan Hambley, MD, MPH
Dr. Bryan Hambley earned his MD and MPH degrees from Tulane University. After residency and chief residency in internal medicine at Case Western, he completed a critical care medicine fellowship at Case Western/University Hospitals. Dr. Hambley is currently a second-year hematology fellow at Johns Hopkins. He plans to practice clinical hematology with a focus on malignant hematology and an emphasis on improving care and access in underserved populations.
Jori May, MD
Dr. Jori May graduated from Washington University in St. Louis School of Medicine before returning to her hometown to complete her residency in internal medicine at the University of Alabama at Birmingham, where she is now a second-year fellow in hematology/oncology. Dr. May plans to pursue a career as a systems-based clinical hematologist, working to improve the care of patients with non-malignant hematologic disorders across health systems.
Marquita Nelson, MD
Dr. Marquita Nelson received her medical degree and completed internal medicine residency at the Emory University School of Medicine. She is currently a second-year hematology/oncology fellow at The University of Chicago. Dr. Nelson’s clinical and research interests include non-malignant hematology and improving the care of adults with sickle cell disease.
Shyam Patel, MD, PhD
Dr. Shyam Patel graduated from Rutgers – New Jersey Medical School, where he performed his thesis research on breast cancer stem cells and the bone marrow microenvironment. He is a prior recipient of the ASH Trainee Research Award. Dr. Patel completed internal medicine residency at Stanford University, and he is currently a third-year hematology/oncology fellow at Stanford University. His current research interests include stem cell biology and acute leukemia. Dr. Patel has a strong interest in academic medicine, including research, clinical care, and medical education.
Daniel Richardson, MD, MA
Dr. Daniel Richardson is a second-year hematology and oncology fellow at the University of North Carolina. In conjunction with a clinical career as a malignant hematologist, focusing on leukemia, his research focuses on cancer outcomes, including unmet needs in cancer care, social and economic disparities, and physician and patient well-being. Dr. Richardson intends to explore ethical issues surrounding the physician-patient relationship, inequities in access and treatment, and the financial consequences of cancer care.
Ze Zheng, PhD
Dr. Ze Zheng is a postdoctoral fellow at Columbia University Medical Center in New York. She received her MBBS in clinical medicine from Jiamusi University in China and her PhD in molecular biology and genetics of liver metabolism from Wayne State University in Detroit, Michigan. Dr. Zheng studies the role of reduced hepatocyte-derived fibrinolytic activity in obesity-associated thrombosis. She is interested in pursuing a career in thrombosis-related translational research.
back to top